Journal article
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
JR Poespoprodjo, FH Burdam, F Candrawati, B Ley, N Meagher, E Kenangalem, R Indrawanti, L Trianty, K Thriemer, DJ Price, JA Simpson, RN Price
Lancet Infectious Diseases | Published : 2022
Abstract
Background: There is a high risk of Plasmodium vivax recurrence in patients treated for Plasmodium falciparum malaria in co-endemic areas. Primaquine radical cure has the potential to reduce P vivax recurrences in patients presenting with P falciparum as well as P vivax malaria but is undermined by poor adherence to the currently recommended 14-day regimen. We aimed to assess the efficacy and safety of supervised versus unsupervised primaquine radical cure in patients presenting with uncomplicated malaria. Methods: We did a cluster-randomised, controlled, open-label superiority trial in Papua, Indonesia. 21 clusters of village health posts, matched by annual parasite index, were randomly ass..
View full abstractRelated Projects (2)
Grants
Awarded by Mahidol University
Funding Acknowledgements
The Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Foreign Affairs and Trade of the Australian Government.